Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP618609.RAB4o2sN1lw5h0l2Lojh6Np7GMVzkV5JiwHxops9CRZ1U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP618609.RAB4o2sN1lw5h0l2Lojh6Np7GMVzkV5JiwHxops9CRZ1U130_assertion type Assertion NP618609.RAB4o2sN1lw5h0l2Lojh6Np7GMVzkV5JiwHxops9CRZ1U130_head.
- NP618609.RAB4o2sN1lw5h0l2Lojh6Np7GMVzkV5JiwHxops9CRZ1U130_assertion wasGeneratedBy ECO_0000203 NP618609.RAB4o2sN1lw5h0l2Lojh6Np7GMVzkV5JiwHxops9CRZ1U130_provenance.
- NP618609.RAB4o2sN1lw5h0l2Lojh6Np7GMVzkV5JiwHxops9CRZ1U130_assertion wasDerivedFrom befree-2016 NP618609.RAB4o2sN1lw5h0l2Lojh6Np7GMVzkV5JiwHxops9CRZ1U130_provenance.
- NP618609.RAB4o2sN1lw5h0l2Lojh6Np7GMVzkV5JiwHxops9CRZ1U130_assertion SIO_000772 17611667 NP618609.RAB4o2sN1lw5h0l2Lojh6Np7GMVzkV5JiwHxops9CRZ1U130_provenance.
- NP618609.RAB4o2sN1lw5h0l2Lojh6Np7GMVzkV5JiwHxops9CRZ1U130_assertion evidence source_evidence_literature NP618609.RAB4o2sN1lw5h0l2Lojh6Np7GMVzkV5JiwHxops9CRZ1U130_provenance.
- NP618609.RAB4o2sN1lw5h0l2Lojh6Np7GMVzkV5JiwHxops9CRZ1U130_assertion description "[Antitumor activity of a combination of trastuzumab (Herceptin) and oral fluoropyrimidine S-1 on human epidermal growth factor receptor 2-overexpressing pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618609.RAB4o2sN1lw5h0l2Lojh6Np7GMVzkV5JiwHxops9CRZ1U130_provenance.